This approach identified highly significant ASM with CpG sites between FADS1 and FADS2 in a putative enhancer signature region, leading to the hypothesis that the phenotypic associations of rs174537 are likely due to methylation differences.
← all excerpts
DNA methylation in an enhancer region of the FADS cluster is associated with FADS activity in human liver.
1
—
—